Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920652 (
skin irritant
)
188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We present in this paper a review of the toxicological and environmental hazards, exposures and risks of tetrahydrofuran (
THF
; CASRN 109-99-9).
THF
is a polar solvent and monomer that is easily absorbed by all routes of exposure. The acute toxicity of
THF
is low to moderate by all routes. Irreversible corrosive damage to the eye can result from direct contact. However,
THF
is neither a
skin irritant
, nor sensitizer. Studies in vitro and in vivo have shown that
THF
is not mutagenic. Chronic studies have found benign tumors in the kidneys of male rats and in the livers of female mice. These findings have been examined, and although a mode of action is not known, the weight of evidence suggests that these tumors are likely not relevant to human health, but instead secondary to rodent-specific modes of action.
THF
produces transient sedative effects in rats at high concentrations but no significant neurobehavioral changes or neuropathology in sub-chronic studies. There were no specific effects reported on reproduction or developmental toxicity in rats or mice, with non-specific developmental toxicity observed only in the presence of significant maternal toxicity. The log K(ow) value for
THF
is less than 3, indicating a low potential for bioaccumulation.
THF
is inherently biodegradable, thus is not expected to be environmentally persistent.
THF
does not present an ecotoxicity hazard based on test results in fish, aquatic invertebrates and plants. Exposures to
THF
in the workplace, to consumers and via environmental releases were modeled and all found to fall below the derived toxicity thresholds.
...
PMID:A review of the toxicological and environmental hazards and risks of tetrahydrofuran. 2414 14